Early anti-pseudomonal acquisition in young patients with cystic fibrosis: Rationale and design of the EPIC clinical trial and observational study,-Reference-Cited by-同舟云学术

Early anti-pseudomonal acquisition in young patients with cystic fibrosis: Rationale and design of the EPIC clinical trial and observational study,

Published:2009-05 Issue:3 Volume:30 Page:256-268
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Treggiari Miriam M.,Rosenfeld Margaret,Mayer-Hamblett Nicole,Retsch-Bogart George,Gibson Ronald L.,Williams Judy,Emerson Julia,Kronmal Richard A.,Ramsey Bonnie W.

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference39 articles.

1. Patient Registry 2004 annual data report;Cystic Fibrosis Foundation,2005

2. The incidence of cystic fibrosis;Kosorok;Stat med,1996

3. Pathophysiology and management of pulmonary infections in cystic fibrosis;Gibson;Am J Respir Crit Care Med,2003

4. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis;Gibson;Am J Respir Crit Care Med,2003

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repurposing against antibiotic resistant bacterial pathogens;European Journal of Medicinal Chemistry;2024-12

2. Genetic modifiers of body mass index in individuals with cystic fibrosis;The American Journal of Human Genetics;2024-09

3. Definitions of pulmonary exacerbation in people with cystic fibrosis: a scoping review;BMJ Open Respiratory Research;2024-08

4. The clinical utility of sequencing the entirety of CFTR;Journal of Cystic Fibrosis;2024-07

5. The Non-Invasive Detection of Pulmonary Exacerbations in Disorders of Mucociliary Clearance with Breath Analysis: A Systematic Review;Journal of Clinical Medicine;2024-06-07